Meet the 2019 Enterprise Awards Finalists & Honorees

Please visit to reserve your commemorative tribute journal message. Reserve your tickets for this year’s Gala here.


Bainbridge Health

Bainbridge Health—a spin-out company of The Children’s Hospital of Philadelphia—is on a mission to enhance safety for patients and reduce costs for hospitals by mitigating the risk of medication errors. Bainbridge Health’s proprietary Med O.S.™ technology is a vendor-agnostic Medication Safety Software Platform now in use at both adult and pediatric systems across the country. It serves as an integral component of these systems’ safety and risk management strategies by helping to limit their risk of avoidable medication errors and subsequent costs in an era of changing payer mixes and reimbursement models.

Praeventix (under development)

Praeventix is a biopharmaceutical company focusing on the discovery, development and marketing of novel signal transduction modulating agents for the treatment of Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) and Crohn’s Disease (CD).

Tmunity Therapeutics

Tmunity Therapeutics is a private biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy to more patients with devastating diseases. Integrating broad collaborations with the University of Pennsylvania (UPenn) and the University of Minnesota with the groundbreaking scientific, clinical and manufacturing expertise and demonstrated track record of its founders, Tmunity is developing personalized immunotherapies for cancer, infectious disease and autoimmune disease that are advancing rapidly toward the clinic.


Augean Robotics

Fully autonomous farming begins with collaborative robots. Augean Robotics is launching a collaborative robotic platform, called Burro, that reduces labor costs for growers of the most labor-intensive crops and paves the way toward the fully autonomous future. Burro follows people, learns the routes and can then rerun them autonomously on its own. Today, Augean Robotics is running paid deployments of Burro with some of the world’s largest growers of specialty crops.


80% of patients that have a behavioral health diagnosis are seen by a primary care provider but never see a behavioral health specialist. 50% of patients that are referred to a specialist never go to their first appointment. NeuroFlow is looking to change this by using AI and machine learning to nudge positive behavior change. NeuroFlow’s digital health platforms promote behavioral healthcare access and engagement in all care settings to improve cost of care, overall wellness and outcomes.


DrayNow is the first real-time Intermodal marketplace, transforming the way freight connects with available Intermodal carriers. The DrayNow Marketplace is accessed by Third-Party Logistics (3PLs), Intermodal Marketing Companies (IMCs), and brokers through a desktop interface where users can view truck capacity in real time, post loads, track load status and obtain electronic documents immediately. With DrayNow’s mobile application, truck drivers can get turnkey access to Intermodal freight, browse loads, compare rates and details, select loads, deliver loads and get paid faster.



Founded in 2014, Allevi’s mission is to make it easy to design and engineer 3D tissues. Its 3D bioprinters and bioinks are used by researchers all around the world to find solutions to humanity’s most difficult problems—to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life.


Tridiuum, Inc., is a digital health company integrating behavioral health into total health. The company’s behavioral health solution accelerates all elements associated with identifying, managing, coordinating and treating behavioral health across the continuum of care. Its cloud-based platform, Tridiuum1, helps to unlock value and profitability by delivering improvements in access, management and outcomes—for patients, providers and health systems.

vybe urgent care

vybe urgent care operates the leading independent network of walk-in urgent care centers in the greater Philadelphia region, with a focus on high-quality medical care and unparalleled patient service. vybe provides a broad range of injury and illness treatments, physical exams and occupational health services. Everyone deserves great care.


AppBus Inc.

The AppBus digital business platform fast-tracks integration to generate end-to-end process automation while enabling secure application delivery to any device. AppBus eXperience Platform combines the power of RPA, API Management and Endpoint Management to seamlessly meet the rising expectations of employees, customers and partners. AppBus leverages existing enterprise assets and enables automation and process transparency, all designed to accelerate the delivery of optimized user experiences.


Guru is the world’s first Revenue Empowerment Network, utilizing AI to make sales, support and customer success teams better at their jobs. Our mission is to reinvent the way teams share and operationalize knowledge. With Guru, the knowledge you need to do your job finds you, when and where you need it most. Guru today serves hundreds of leading enterprises such as Shopify, Square, Spotify, Autodesk and Yext.

Phenom People

Phenom People is redefining what it means to search for a job and recruit top talent. Phenom People is the global leader in Talent Relationship Marketing (TRM), empowering talent acquisition and management teams to discover, engage and retain talent through a single platform approach. The Phenom People platform is built on artificial intelligence (AI), which drives personalization, automation and accuracy for all of the stakeholders in the talent lifecycle. People should be happy and inspired by their job.


EIR Healthcare

EIR Healthcare is a healthcare innovation company focused on bringing efficient industrial practices to the healthcare sector. Its flagship product, MedModular, is a factory-made “hospital room in a box,” pre-fabricated based upon recognized industry best practices and delivered on-site. EIR Healthcare collaborates with each hospital to customize the space for the optimal workflow and patient experience. As the leading innovator of cost-effective, efficient and state-of-the-art healthcare, EIR Healthcare improves quality of care in facilities, allowing for the redistribution of funds from construction to human capital, new research and other core functions. EIR Healthcare is making hospitals more patient-centric and ready for the future.

Micro Interventional Devices, Inc. (MID)

Micro Interventional Devices (MID) is a medical device company that designs, manufactures and commercializes disruptive technologies for use in percutaneous and minimally invasive structural heart repair procedures. Its technology can eliminate the need for open-heart surgery or cardiopulmonary bypass and reduce procedure time and hospital stay and recovery time. While the applications of the technology are expansive, MID focuses on three important unmet needs in structural heart disease: Access and closure, mitral and tricuspid valve repair and mitral valve replacement.

Tandigm Health

Tandigm Health is a population health services organization that partners with over 400 primary care physicians to enhance their ability to provide the finest possible care to the 110,000 patients in its network. By providing meaningful incentives, data and a powerful suite of preventive and chronic care programs, Tandigm Health partners with its physician network to keep patients on a path to health and out of the hospital and ER settings, making healthcare more affordable.


Essential Medical

Essential Medical, Inc., was a privately held medical device company that developed and commercialized the CE Marked MANTA™ Vascular Closure Device specifically designed for closure of large bore arteriotomies. Complex vascular procedures such as aortic valve replacement and aortic aneurysm repair are moving toward minimally invasive approaches, but traditional approaches to vascular closure at the end of the procedure often caused complications and led to costly and prolonged hospitalization. In its CE Mark study, the MANTA Device demonstrated rapid and reliable hemostasis with its resorbable collagen-based technology and complication rates that were non-inferior to surgical and suture-based closure methods.

Essential Medical was acquired by Teleflex Incorporated in October 2018. While physician adoption of the MANTA Device in international markets has been impressive, with over 8,000 procedures completed across a number of countries in the EU, Essential Medical felt an outside partner, with established sales and marketing channels, was needed to help MANTA reach its full market potential. Teleflex’s strong presence in the interventional cardiology market made it an ideal partner to accelerate adoption and growth of this breakthrough technology worldwide.


LiquidHub was a customer engagement company that partnered with businesses to improve customer experience and drive growth. LiquidHub was founded in 2001 as a technology solutions business, providing deep technology integration expertise. Over 17 years, LiquidHub expanded from a local IT company to a global customer engagement agency. From 2011 to 2016, the company quickly expanded, quadrupling in size. During this growth period, the company acquired multiple companies with varying areas of expertise, including analytics, digital marketing, industrial and digital design, cognitive science and cloud services. Its organic growth and smart acquisitions enabled LiquidHub to continue growing each year. In February 2018, Capgemini, a global leader in consulting and technology, acquired LiquidHub for $496 million. Through the acquisition, Capgemini reinforced its digital consulting capabilities and accelerated its portfolio shift in North America.


Velicept is a clinical-stage development company founded in 2015 to develop solabegron, a highly differentiated next-generation beta-3 agonist for the treatment of overactive bladder (OAB). The company has developed a proprietary formulation that incorporates the intrinsic properties of solabegron to create an optimized best-in-class product. A strong IP estate protects both the molecule and the formulation out through 2036. Solabegron has the potential to disrupt the $4 billion OAB market with a next-generation agent offering improved relief of symptoms for OAB patients. In 2018, Velicept raised approximately $23.5 million of equity and closed a $15 million debt facility. The capital is being used to fund two large Phase 2 dose ranging studies and ongoing Phase 3 work to create the most time-efficient path to market.



SEI is a leading global provider of outsourced asset management, investment processing, and investment operations solutions that help corporations, financial institutions, financial advisors and affluent families create and manage wealth.

SEI Trade is a web-based solution that digitizes and streamlines the end-to-end processing of investor transactions and onboarding, while facilitating the review, approval, tracking and delivery of subscription documentation and investor data:

  • Transforms any form into digital, guided, wizard-based experience.
  • APIs automate the pre-fill of forms from existing data sources.
  • Configurable conditions/business rules validate data and ensure that processes are completed in good order with messaging and alerts to assist end users.
  • Customizable workflows can be designed to digitize the entire business process with various review assignments and data integration points to allow for straight-thru processing.



Accolade is a personalized health and benefits solution that dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members. Connecting the widest array of personal health data and programs, Accolade presents a single point of contact to the most effective health and benefits resources, while coordinating with providers at every step. Combining technology and human expertise in new ways, Accolade is changing how employees and their family members access and use the employee healthcare and benefits programs they need to live healthier, happier and more productive lives.

Frontline Education

Frontline Education provides human capital management for K-12 education, serving over 12,000 educational organizations, 80,000 schools, and millions of educators, administrators and support personnel. Bringing together people, programs and processes from 12 companies since 2014, Frontline has built the first fully integrated human capital management platform for the K-12 market.


InstaMed powers a better healthcare payments experience through one platform that connects consumers, providers and payers for every healthcare payment transaction. InstaMed’s patented technology seamlessly drives electronic transactions, securely moving money and related healthcare data to the benefit of all those involved in the healthcare payment ecosystem.  


Clutch, Ned Moore, CEO

Founded in 2012, Clutch has revolutionized how marketing teams for premier brands develop and foster relationships with their customers. Its advanced marketing platform serves as a customer hub, delivering deep intelligence derived from real-time behaviors and transactions across in-store, online, mobile and social channels.

Ned Moore is one of the key visionaries behind Clutch, helping identify the tremendous gap in how business-to-consumer (B2C) companies manage and leverage their existing customers. Moore’s management philosophy was shaped by mentors who helped him understand that successfully growing a business depends on attracting the right people to an organization and then empowering them to succeed themselves.

Dell Boomi, Chris McNabb, CEO

Dell Boomi, an independent business unit of Dell, brings far greater organizational speed and agility to any business. The Boomi integration platform as a service (iPaaS) dramatically transforms the way an organization can connect, create, manage and govern its applications and data. Since Dell acquired Boomi in November 2010, Boomi has become the fastest-growing acquisition in Dell’s history, as it helps businesses from around the world and across industries address their most daunting integration challenges.

Chris McNabb is the Chief Executive Officer of Dell Boomi, where he is responsible for all operations and strategic direction. Chris brings more than 20 years of software development and line of business experience from a diverse set of prior roles. Under Chris’ leadership, Dell Boomi met an aggressive and impressive five-year revenue goal in only three years. Boomi has grown from 4,800 to more than 7,500 customers, and the number of employees has increased from 500 to 800+ globally, with expanded operations throughout the EMEA and APJ regions. During this high-growth period, Chris has been fiercely protective of the company’s corporate culture.

Sidecar, Andre Golsorkhi, CEO

Sidecar is a technology company dedicated to retail. Its mission is to maximize the value of performance marketing. By combining deep data, knowledgeable humans and inspired technology, Sidecar is the magic behind retail’s smartest marketing campaigns.

Andre Golsorkhi is a technology entrepreneur with a history of creating organizations that help advance the digital transformation of retail. His most recent venture is Sidecar, a technology company based in Philadelphia. Under Golsorkhi’s guidance as CEO, Sidecar continues to grow quickly to meet customer needs—tripling staff over the past three years and securing $24 million in financing to date. Golsorkhi previously founded Omeda, a development firm specializing in emerging web technologies, and MediLync, a mobile patient accounting software for healthcare professionals.


BioTelemetry, Joseph H. Capper, President and CEO

BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care. It provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials and original equipment manufacturing that serves both healthcare and clinical research customers.

Joseph Capper has been President and Chief Executive Officer of BioTelemetry since 2010. Prior to joining BioTelemetry, Capper served as President, Chief Executive Officer and a member of the board of directors of Home Diagnostics, Inc. (NASDAQ:HDIX), a leading developer, manufacturer and marketer of diabetes management products, which he joined in 2009. Prior to joining Home Diagnostics, from 2002 to 2009, he was President and Chief Executive Officer of CCS Medical Inc., a private company that is a leading provider of medical supplies in diabetes, wound care, respiratory and other therapeutic categories.

Galera Therapeutics, J. Mel Sorensen, M.D., President and CEO

Galera Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on discovering and developing novel therapeutics targeting oxygen metabolic pathways with the potential to transform how radiation therapy is used in patients with cancer. The FDA has granted Fast Track and Breakthrough Therapy designations to avasopasem manganese, Galera’s lead product candidate. In September 2018, Galera announced a financing of $150 million, which permits the company to advance avasopasem manganese through Phase 3 and to New Drug Application submission.

Galera’s success is inextricably linked with Dr. J. Mel Sorensen’s leadership. Dr. Sorensen took the helm of Galera upon its founding in 2012. His experiences as a physician, a researcher and in clinical development have helped him lead a small, research-focused company. His previous experience with raising over $300 million in private financing rounds and licensing deals paved the way for Galera’s successful fundraises ($11 million, $57 million and $150 million) to propel the company forward on its path toward revolutionizing radiotherapy in cancer treatment.

Nevakar, Navneet Puri, CEO

Nevakar is a fully integrated specialty pharmaceutical company, focused on developing innovative ophthalmic and injectable products. Nevakar’s business model is built around drug repositioning and repurposing. These drug repositioning efforts are focused on studying new therapeutic indication of existing molecules; developing novel or superior formulations; designing improved, safer and more functional packaging; and implementing effective regulatory and clinical strategies that support new uses or indications.

Nevakar was founded in 2015 by Dr. Navneet Puri, a successful scientist and entrepreneur. His vision is to establish a sustainable and scalable novel product differentiation approach targeted to address unmet clinical and commercial needs for established molecules. After forming the company and establishing its unique business model, Dr. Puri focused on building an experienced team. He remains deeply engaged in portfolio strategy and selection and played a major role in a series of fundraises for the company (a total of $120M in three years).

Legend Honoree

Howard Ross
LLR Partners

Howard Ross co-founded LLR Partners in 1999. LLR Partners is a middle market private equity firm committed to creating long-term value by growing its portfolio companies. The firm invests primarily in software, healthcare, education, security and fintech businesses. With more than $3.5 billion raised across five funds, LLR is a flexible provider of capital for growth, recapitalizations and buyouts.

Howard is currently a member of the Board of Directors of Agility Recovery Solutions, Key2Act,
Numotion, Rapid Ratings and Rizing. He has also served on the boards of Alsbridge, BrightHeart Veterinary Centers, eResearch Technology, excelleRx, Five Below, Gestalt, InnaPhase, Iron Mountain, Maxwell Systems, Medmark, Pet360, SDI Health, SEI Investments, Singer Equities, Taratec and UltiSat.

Prior to forming LLR, Howard was the partner in charge of Arthur Andersen’s Growth Company Practice in the Greater Philadelphia market. In his 26 years at Arthur Andersen, he built a practice of over 80 people, including five partners, serving over 175 rapidly growing companies.

Howard holds a B.S. in Economics from the Wharton School of the University of Pennsylvania, graduating summa cum laude. Howard and his wife, Susan, live in Bryn Mawr, PA with their two dogs. Their two children, Matt and Rachael, are in their 30s and live in Manhattan and Chapel Hill.

©2020 PACT All Rights Reserved